Financial Reports Latest Updates Industry Maps Economic Calendar

KAMADA LTD (KMDA) Annual Reports

Q: Where can I read KAMADA LTD (KMDA) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

KAMADA LTD is listed on Nasdaq, classified by the SEC under Pharmaceutical Preparations (SIC 2834). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 1567529 →

Website：Official site ↗

Financial Highlights

FY2025 Q3 (quarterly, ended 2025-09-30)
	Current	Prior year	YoY
Revenue	$47.0M	$41.7M	+12.6%
Operating income	$7.8M	$5.3M	+47.6%
Net income	$5.3M	$3.9M	+37.1%
EPS (diluted)	$0.09	$0.07	+28.6%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue -82.1 mn Net income 3.56 mn

Show table：Income statement

Item	2015Q4	2016Q4	2017Q4	2018Q4	2019Q4	2020Q3	2020Q4	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4
Revenue	69.9	77.5	103	114	127	35.3	31.5	24.2	23.0	-15.9	28.1	23.6	32.2	-41.2	30.7	37.4	0.04	58.0	0.04	42.5	41.7	-42.9	44.0	44.8	47.0	-82.1
Gross profit	15.4	21.4	32.1	41.5	49.7	14.8	10.2	9.07	5.73	6.60	11.3	7.24	12.9	15.3	11.8	14.4	0.01	55.5	0.02	18.9	17.2	17.0	20.8	18.9	19.8	17.0
Operating income	-11.4	-5.48	7.44	19.3	22.8	7.76	2.65	1.05	-0.8	-3.30	0.25	-2.29	2.56	4.02	0.29	2.63	0	10.1	0	5.64	5.29	5.08	7.80	7.07	7.82	3.55
Net income	-11.3	-6.73	6.90	22.3	22.3	6.84	1.63	0.94	-0.84	-5.01	-1.83	-3.92	0	-2.32	0	1.81	0	0.01	0	4.43	3.86	3.81	3.96	7.38	5.30	3.56

Balance sheet

Quarterly · In mn (USD)

Total assets 379 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2015Q4	2016Q4	2017Q4	2018Q4	2019Q4	2020Q3	2020Q4	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4
Current assets	—	77.1	96.9	111	144	175	178	179	179	130	116	119	135	139	131	130	0.15	170	0.16	166	164	184	189	183	193	193
Total assets	—	99.7	122	138	174	206	211	216	217	319	303	304	320	322	317	314	0.34	355	0.34	351	351	372	375	368	377	379
Current liabilities	—	27.2	29.4	23.6	32.7	23.2	25.0	26.1	26.6	54.1	42.2	49.7	69.2	75.7	69.3	65.8	0.04	49.6	0.04	40.9	34.0	49.4	57.0	45.8	47.8	47.4
Equity	72.5	66.7	89.5	112	135	177	179	182	182	177	175	172	173	176	175	177	0.24	244	0.25	251	255	259	252	260	265	269

Cash flow

Quarterly · In mn (USD)

Operating 7.57 mn Investing -2.77 mn Financing -1.18 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2015Q4	2016Q4	2017Q4	2018Q4	2019Q4	2020Q3	2020Q4	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4
Operating	-14.0	1.90	3.61	10.6	27.6	2.38	12.8	-3.28	-2.67	-4.97	5.47	10.9	5.49	6.74	-2.85	1.82	0	4.32	0	14.0	22.2	10.4	-0.51	8.02	10.4	7.57
Investing	11.3	1.64	-15.6	-5.18	-0.56	-1.47	5.88	10.6	34.6	-95.7	-0.51	-0.68	-1.62	-0.98	-1.09	-1.05	0	-5.84	0	-3.01	-2.12	-2.92	-1.46	-2.01	-3.59	-2.77
Financing	-6.35	1.49	15.3	-0.59	-1.53	-0.36	-0.4	-0.39	-0.32	19.7	-1.81	-2.40	-2.26	-2.87	-2.88	-5.85	0.03	22.7	-0.01	-2.68	-4.79	-0.71	-0.29	-16.1	-0.75	-1.18
Cash at period end	5.05	9.97	12.7	18.1	42.7	52.5	70.2	68.4	99.8	18.6	22.0	29.9	31.3	34.3	27.1	21.8	0.05	55.6	0.05	56.5	72.0	78.4	76.3	66.0	72.0	75.5

Profitability

Quarterly · %

Gross margin 42.0% Operating margin 16.6% Net margin 11.3%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2015Q4	2016Q4	2017Q4	2018Q4	2019Q4	2020Q3	2020Q4	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4
Gross margin	22.0%	27.6%	31.2%	36.2%	39.1%	42.0%	32.2%	37.4%	24.9%	—	40.2%	30.7%	40.0%	—	38.5%	38.5%	39.0%	95.5%	44.4%	44.6%	41.3%	—	47.1%	42.3%	42.0%	—
Operating margin	-16.3%	-7.1%	7.2%	16.8%	17.9%	22.0%	8.4%	4.3%	-3.5%	—	0.9%	-9.7%	8.0%	—	0.9%	7.0%	11.5%	17.3%	10.7%	13.3%	12.7%	—	17.7%	15.8%	16.6%	—
Net margin	-16.1%	-8.7%	6.7%	19.5%	17.5%	19.4%	5.2%	3.9%	-3.7%	—	-6.5%	-16.6%	0.0%	—	-0.0%	4.8%	8.5%	0.0%	6.3%	10.4%	9.3%	—	9.0%	16.5%	11.3%	—

Returns & leverage

Quarterly · %

ROE 7.6% ROA 5.4%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2015Q4	2016Q4	2017Q4	2018Q4	2019Q4	2020Q3	2020Q4	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4
ROE	—	—	—	10.0%	43.0%	47.9%	39.5%	21.5%	5.4%	-1.9%	-3.8%	-6.6%	-6.1%	-4.6%	-3.6%	-0.3%	-0.6%	0.9%	2.1%	2.1%	6.5%	4.8%	12.7%	7.4%	7.9%	7.6%
ROA	—	—	—	8.1%	25.7%	38.1%	31.9%	17.9%	4.4%	-1.3%	-2.6%	-4.5%	-4.0%	-2.5%	-2.0%	-0.2%	-0.3%	0.5%	1.1%	1.3%	4.7%	3.3%	8.6%	5.3%	5.6%	5.4%

EPS

Quarterly · US$

EPS US$0.06

Show table：EPS

Item	2015Q4	2016Q4	2017Q4	2018Q4	2019Q4	2020Q3	2020Q4	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4
EPS（US$）	-0.31	-0.18	0.18	0.55	0.55	0.15	0.03	0.02	-0.02	-0.11	-0.04	-0.09	0.01	0.07	-0.04	0.04	0.06	0.09	0.04	0.08	0.07	0.07	0.07	0.13	0.09	0.06

Revenue & profit

Year-to-date · In mn (USD)

Revenue 53.6 mn Net income 20.2 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 379 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating 25.5 mn Investing -9.84 mn Financing -18.3 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Gross margin 142.4% Operating margin 48.9% Net margin 37.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE 7.6% ROA 5.4%

EPS

Year-to-date · US$

EPS US$0.35

Revenue & profit

Annual · In mn (USD)

Revenue 53.6 mn Net income 20.2 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2022	2023	2024	2025
Revenue	42.7	126	41.4	53.6
Gross profit	46.7	81.7	53.2	76.4
Operating income	4.53	13.0	16.0	26.2
Net income	-8.06	1.82	12.1	20.2

Balance sheet

Annual · In mn (USD)

Total assets 379 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2022	2023	2024	2025
Current assets	139	170	184	193
Total assets	322	355	372	379
Current liabilities	75.7	49.6	49.4	47.4
Equity	176	244	259	269

Cash flow

Annual · In mn (USD)

Operating 25.5 mn Investing -9.84 mn Financing -18.3 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2022	2023	2024	2025
Operating	28.6	3.28	46.6	25.5
Investing	-3.78	-7.98	-8.06	-9.84
Financing	-9.34	13.9	-8.18	-18.3
Cash at period end	34.3	55.6	78.4	75.5

Profitability

Annual · %

Gross margin 142.4% Operating margin 48.9% Net margin 37.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2022	2023	2024	2025
Gross margin	109.5%	64.8%	128.7%	142.4%
Operating margin	10.6%	10.3%	38.7%	48.9%
Net margin	-18.9%	1.4%	29.2%	37.6%

Returns & leverage

Annual · %

ROE 7.6% ROA 5.4%

Show table：Returns & leverage

Item	2022	2023	2024	2025
ROE	-4.6%	0.9%	4.8%	7.6%
ROA	-2.5%	0.5%	3.3%	5.4%

EPS

Annual · US$

EPS US$0.35

Show table：EPS

Item	2022	2023	2024	2025
EPS（US$）	-0.05	0.15	0.26	0.35

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	20-F
2025	Open full text →
2024	Open full text →
2023	Open full text →

20-F: annual report of a foreign private issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read KAMADA LTD (KMDA) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.